CNS pipeline · person
Adam Koppel, MD, PhD
Director of Cerevel Therapeutics since September 2018, nominated to the board by BC Perception Holdings (Bain Capital). Partner of Bain Capital Life Sciences; previously executive vice president of corporate development and chief strategy officer at Biogen.
- 1 company
Courtesy Cerevel Therapeutics
Current roles
- Cerevel TherapeuticsDirector · Board2018–present
Appears with
People sharing a company with Adam.
- Christopher Gordon · Cerevel Therapeutics
- Deborah Baron · Cerevel Therapeutics
- Deval Patrick · Cerevel Therapeutics
- Doug Giordano · Cerevel Therapeutics
- Gabrielle Sulzberger · Cerevel Therapeutics
- John Renger · Cerevel Therapeutics
- Kathleen Tregoning · Cerevel Therapeutics
- Kenneth DiPietro · Cerevel Therapeutics
- Marijn Dekkers · Cerevel Therapeutics
- Mark Bodenrader · Cerevel Therapeutics
- N. Anthony Coles · Cerevel Therapeutics
- Norbert G. Riedel · Cerevel Therapeutics
- Paul Burgess · Cerevel Therapeutics
- Raymond Sanchez · Cerevel Therapeutics
- Ron Renaud · Cerevel Therapeutics
- Ruth McKernan · Cerevel Therapeutics
- Scott Akamine · Cerevel Therapeutics
- Suneet Varma · Cerevel Therapeutics
- Susan Altschuller · Cerevel Therapeutics
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.